메뉴 건너뛰기




Volumn 52, Issue 7, 2012, Pages 1120-1129

Treatment-resistant medication overuse headache can be cured

Author keywords

follow up; medication overuse headache; multidisciplinary treatment; outpatient treatment; treatment resistant headache

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; FLUNARIZINE; LEVOMEPROMAZINE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROMETHAZINE; TOPIRAMATE; TRIPTAN DERIVATIVE;

EID: 84863728678     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02191.x     Document Type: Article
Times cited : (53)

References (33)
  • 1
    • 79953057457 scopus 로고    scopus 로고
    • Prevalence of headache in Europe: A review for the Eurolight project
    • Stovner LJ, Andree C,. Prevalence of headache in Europe: A review for the Eurolight project. J Headache Pain. 2010; 11: 289-299.
    • (2010) J Headache Pain , vol.11 , pp. 289-299
    • Stovner, L.J.1    Andree, C.2
  • 2
    • 77949327358 scopus 로고    scopus 로고
    • Clinical features, pathophysiology, and treatment of medication-overuse headache
    • Evers S, Marziniak M,. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010; 9: 391-401.
    • (2010) Lancet Neurol , vol.9 , pp. 391-401
    • Evers, S.1    Marziniak, M.2
  • 3
    • 84859815299 scopus 로고    scopus 로고
    • The cost of headache disorders in Europe: The Eurolight project
    • Linde M, Gustavsson A, Stovner LJ, et al,. The cost of headache disorders in Europe: The Eurolight project. Eur J Neurol. 2012; 19: 703-711.
    • (2012) Eur J Neurol , vol.19 , pp. 703-711
    • Linde, M.1    Gustavsson, A.2    Stovner, L.J.3
  • 5
    • 78650119650 scopus 로고    scopus 로고
    • Reduction in medication-overuse headache after short information. The Akershus study of chronic headache
    • Grande RB, Aaseth K, Benth JS, Lundqvist C, Russell MB,. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011; 18: 129-137.
    • (2011) Eur J Neurol , vol.18 , pp. 129-137
    • Grande, R.B.1    Aaseth, K.2    Benth, J.S.3    Lundqvist, C.4    Russell, M.B.5
  • 6
    • 79951609300 scopus 로고    scopus 로고
    • Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache
    • Rossi P, Faroni JV, Nappi G,. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2010; 18: 396-401.
    • (2010) Eur J Neurol , vol.18 , pp. 396-401
    • Rossi, P.1    Faroni, J.V.2    Nappi, G.3
  • 7
    • 78049247477 scopus 로고    scopus 로고
    • Medication overuse headache: A critical review of end points in recent follow-up studies
    • Hagen K, Jensen R, Boe MG, Stovner LJ,. Medication overuse headache: A critical review of end points in recent follow-up studies. J Headache Pain. 2010; 11: 373-377.
    • (2010) J Headache Pain , vol.11 , pp. 373-377
    • Hagen, K.1    Jensen, R.2    Boe, M.G.3    Stovner, L.J.4
  • 8
    • 34249021087 scopus 로고    scopus 로고
    • Medication overuse headaches
    • Olesen J. Goadsby P.J. Ramadan N. Tfelt-Hansen P. Welch K.M.A. eds. Philadelphia, PA: Lippincott Williams & Wilkins
    • Diener HC, Silberstein SD,. Medication overuse headaches. In:, Olesen J, Goadsby PJ, Ramadan N, Tfelt-Hansen P, Welch KMA, eds. The Headaches. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 971-979.
    • (2006) The Headaches , pp. 971-979
    • Diener, H.C.1    Silberstein, S.D.2
  • 9
    • 58449103368 scopus 로고    scopus 로고
    • Management of medication overuse headache: 1-year randomized multicentre open-label trial
    • Hagen K, Albretsen C, Vilming S, et al,. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2008; 29: 221-232.
    • (2008) Cephalalgia , vol.29 , pp. 221-232
    • Hagen, K.1    Albretsen, C.2    Vilming, S.3
  • 10
    • 79952112829 scopus 로고    scopus 로고
    • Predictors of outcome of the treatment programme in a multidisciplinary headache centre
    • Jensen R, Zeeberg P, Dehlendorff C, Olesen J,. Predictors of outcome of the treatment programme in a multidisciplinary headache centre. Cephalalgia. 2010; 30: 1214-1224.
    • (2010) Cephalalgia , vol.30 , pp. 1214-1224
    • Jensen, R.1    Zeeberg, P.2    Dehlendorff, C.3    Olesen, J.4
  • 11
    • 33745184401 scopus 로고    scopus 로고
    • New appendix criteria open for a broader concept of chronic migraine
    • Olesen J, Bousser MG, Diener HC, et al,. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-746.
    • (2006) Cephalalgia , vol.26 , pp. 742-746
    • Olesen, J.1    Bousser, M.G.2    Diener, H.C.3
  • 13
    • 84864642676 scopus 로고    scopus 로고
    • Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: Proposals for the optimal detoxification programme
    • (in press)
    • Munksgaard SB, Bendtsen L, Jensen RH,. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: Proposals for the optimal detoxification programme. Cephalalgia. 2012 (in press).
    • (2012) Cephalalgia
    • Munksgaard, S.B.1    Bendtsen, L.2    Jensen, R.H.3
  • 14
  • 15
    • 68849130671 scopus 로고    scopus 로고
    • EFNS guideline on the drug treatment of migraine - Revised report of an EFNS task force
    • Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS,. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol. 2009; 16: 968-981.
    • (2009) Eur J Neurol , vol.16 , pp. 968-981
    • Evers, S.1    Afra, J.2    Frese, A.3    Goadsby, P.J.4    Linde, M.5    May, A.6    Sandor, P.S.7
  • 16
    • 0035083329 scopus 로고    scopus 로고
    • Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability
    • Stewart WF, Lipton RB, Dowson AJ, Sawyer J,. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001; 56: S20-S28.
    • (2001) Neurology , vol.56
    • Stewart, W.F.1    Lipton, R.B.2    Dowson, A.J.3    Sawyer, J.4
  • 17
    • 0031010914 scopus 로고    scopus 로고
    • Quality of life assessment: The World Health Organization perspective
    • Saxena S, Orley J,. Quality of life assessment: The World Health Organization perspective. Eur Psychiatry. 1997; 12S3: 263s-266s.
    • (1997) Eur Psychiatry , vol.123
    • Saxena, S.1    Orley, J.2
  • 19
    • 65449152400 scopus 로고    scopus 로고
    • Chronic daily headache with medication overuse: A randomized follow-up by neurologist or PCP
    • BÃe MG, Salvesen R, Mygland A,. Chronic daily headache with medication overuse: A randomized follow-up by neurologist or PCP. Cephalalgia. 2009; 29: 855-863.
    • (2009) Cephalalgia , vol.29 , pp. 855-863
    • Bãe, M.G.1    Salvesen, R.2    Mygland, A.3
  • 20
  • 23
    • 0037799478 scopus 로고    scopus 로고
    • Rates and predictors for relapse in medication overuse headache: A 1-year prospective study
    • Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G,. Rates and predictors for relapse in medication overuse headache: A 1-year prospective study. Neurology. 2003; 60: 1682-1683.
    • (2003) Neurology , vol.60 , pp. 1682-1683
    • Katsarava, Z.1    Limmroth, V.2    Finke, M.3    Diener, H.C.4    Fritsche, G.5
  • 24
    • 35248868748 scopus 로고    scopus 로고
    • Disability in chronic migraine with medication overuse: Treatment effects at 3 years
    • Andrasik F, Grazzi L, Usai S, D'Amico D, Kass S, Bussone G,. Disability in chronic migraine with medication overuse: Treatment effects at 3 years. Headache. 2007; 47: 1277-1281.
    • (2007) Headache , vol.47 , pp. 1277-1281
    • Andrasik, F.1    Grazzi, L.2    Usai, S.3    D'Amico, D.4    Kass, S.5    Bussone, G.6
  • 25
    • 53549085952 scopus 로고    scopus 로고
    • Medication overuse headache: Predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study
    • Rossi P, Faroni JV, Nappi G,. Medication overuse headache: Predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008; 28: 1196-1200.
    • (2008) Cephalalgia , vol.28 , pp. 1196-1200
    • Rossi, P.1    Faroni, J.V.2    Nappi, G.3
  • 26
    • 65549090939 scopus 로고    scopus 로고
    • Psychological variables in chronic migraine with medication overuse before and after inpatient withdrawal: Results at 1-year follow-up
    • Usai S, Grazzi L, D'Amico D, Andrasik F, Bussone G,. Psychological variables in chronic migraine with medication overuse before and after inpatient withdrawal: Results at 1-year follow-up. Neurol Sci. 2009; 30 (Suppl. 1): S125-S127.
    • (2009) Neurol Sci , vol.30 , Issue.1 SUPPL.
    • Usai, S.1    Grazzi, L.2    D'Amico, D.3    Andrasik, F.4    Bussone, G.5
  • 27
    • 33748502994 scopus 로고    scopus 로고
    • Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness
    • Zeeberg P, Olesen J, Jensen R,. Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness. Cephalalgia. 2006; 26: 1192-1198.
    • (2006) Cephalalgia , vol.26 , pp. 1192-1198
    • Zeeberg, P.1    Olesen, J.2    Jensen, R.3
  • 28
    • 45249108007 scopus 로고    scopus 로고
    • In-patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: Results at one-year follow-up
    • Grazzi L, Andrasik F, Usai S, Bussone G,. In-patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: Results at one-year follow-up. Neurol Sci. 2008; 29 (Suppl. 1): S161-S163.
    • (2008) Neurol Sci , vol.29 , Issue.1 SUPPL.
    • Grazzi, L.1    Andrasik, F.2    Usai, S.3    Bussone, G.4
  • 29
    • 0035856421 scopus 로고    scopus 로고
    • Clinical features of withdrawal headache following overuse of triptans and other headache drugs
    • Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V,. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001; 57: 1694-1698.
    • (2001) Neurology , vol.57 , pp. 1694-1698
    • Katsarava, Z.1    Fritsche, G.2    Muessig, M.3    Diener, H.C.4    Limmroth, V.5
  • 31
    • 34247120060 scopus 로고    scopus 로고
    • Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study
    • Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ,. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia. 2007; 27: 814-823.
    • (2007) Cephalalgia , vol.27 , pp. 814-823
    • Diener, H.C.1    Bussone, G.2    Van Oene, J.C.3    Lahaye, M.4    Schwalen, S.5    Goadsby, P.J.6
  • 33
    • 77957845439 scopus 로고    scopus 로고
    • Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: Randomised controlled trial
    • Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, Himawan L,. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: Randomised controlled trial. BMJ. 2010; 341: c4871.
    • (2010) BMJ , vol.341
    • Holroyd, K.A.1    Cottrell, C.K.2    O'Donnell, F.J.3    Cordingley, G.E.4    Drew, J.B.5    Carlson, B.W.6    Himawan, L.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.